Application submitted for an already approved NDA for any changes in packaging, labeling, dosages, ingredients or new indications.
Glossary
Supplemental New Drug Application (sNDA)
02.27.12
-
Breaking News | Drug Development
Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio
Expands its oncology leadership capabilities in the U.S.Charles Sternberg, Assistant Editor
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
LSNE, Selecta Biosciences Form Mfg. Pact
LSNE to provide drug substance manufacturing and fill/finish services
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Selexis SA and OSE Immunotherapeutics Enter Pact
Sign agreement for the development of OSE's interleukin receptor 7 antagonist
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News | Preclinical Outsourcing
Crown Bioscience Enters Antibody Collaboration
Will develop a CTLA-4 antibody with Jiangsu Qyun Bio-Pharmaceutical
-
Bio News | Breaking News | Clinical Trials | Drug Development | Industry News
Espero Pharma and Armetheon Merge
Creates a premier cardiovascular focused biopharmaceutical company
